Checkpoint inhibitor immune-related adverse events as a prognosis factor in urothelial cancer: A retrospective analysis
Authors:
- A.Q. ParmanandeAPA.Q. Parmanande
- J.V. BarreiraJ.V. Barreira
- A.S. SpencerASA.S. Spencer
- D.C. SimãoDSD.C. Simão
- A.F. Palma Dos ReisARA.F. Palma Dos Reis
- M. SardinhaMSM. Sardinha
- R. LuzRLR. Luz
- 15 November 2019
- journal article
- abstracts
- Published by Elsevier in European Urology Supplements
- Vol. 18 (11) , e3608